CRMI (08158) 1H profit HK$2.22M, down 86% X
12/08/2022 18:03
(Infocast News)      Results of China Regenerative Medicine International Limited (08158) for the first half-year ended 30 June 2022:

Net profit: HK$2.222M, down 86.32% YoY (HK$16.239M net profit for the same period last year) 
Basic EPS: HK$0.0008
Dividend per share proposed: (Nil)


Infocast Limited and its information providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.